Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury

Area of Science:

• Cardiovascular Research
• Immunology
• Molecular Biology

Background:

• Proinflammatory cytokines drive cardiac dysfunction post-ischemia-reperfusion.
• The exact mechanism inducing this innate immune response is unclear.
• Toll-like receptor 2 (TLR2) is involved in innate immunity and may respond to noninfectious injury.

Purpose of the Study:

• To investigate the role of TLR2 in myocardial inflammation and left ventricular (LV) function during ischemia-reperfusion injury.
• To determine if TLR2 deficiency protects against ischemia-reperfusion-induced cardiac dysfunction.

Main Methods:

• Langendorff-perfused hearts from wild-type and TLR2-deficient (TLR2D) mice were subjected to ischemia-reperfusion.
• Cardiac contractile performance (LV developed pressure) and creatinine kinase levels were assessed.
• Cardiac levels of TNF and IL-1beta were measured.
• The effect of etanercept (TNF blocking protein) on LV dysfunction was evaluated.

Main Results:

• Wild-type hearts showed significantly impaired contractile performance post-ischemia-reperfusion compared to TLR2D hearts.
• Elevated cardiac TNF and IL-1beta levels were observed in wild-type hearts.
• LV dysfunction in wild-type hearts was reversed by etanercept treatment.
• Creatinine kinase levels were comparable between groups.

Conclusions:

• TLR2 signaling significantly contributes to left ventricular dysfunction following ischemia-reperfusion injury.
• Disrupting TLR2-mediated signaling may offer myocardial protection against ischemia-reperfusion.
• TLR2 represents a potential therapeutic target for mitigating cardiac damage.